Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Roche Diabetes Care, Inc., a prominent player in the diabetes management industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1896, Roche has established itself as a leader in innovative healthcare solutions, particularly in diabetes care. The company is renowned for its cutting-edge blood glucose monitoring systems, insulin delivery devices, and digital health solutions, which empower patients to manage their diabetes effectively.
Roche Diabetes Care's unique approach combines advanced technology with user-friendly design, ensuring that individuals with diabetes can easily monitor their health. With a strong market position, the company has achieved notable milestones, including the development of the Accu-Chek product line, which is widely recognised for its reliability and accuracy. Through continuous innovation and a commitment to improving patient outcomes, Roche Diabetes Care remains at the forefront of diabetes management solutions.
+46 vs industry average
Roche Diabetes Care, Inc.’s score of 88 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Roche Diabetes Care, Inc. yet.
Roche Diabetes Care, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Roche Holding AG, which influences its climate commitments and emissions reporting.
As part of its corporate family, Roche Diabetes Care inherits emissions data and climate initiatives from Roche Holding AG. However, there are no documented reduction targets or specific climate pledges available for Roche Diabetes Care at this time. The absence of detailed emissions data and reduction initiatives suggests that the company may still be in the process of establishing its own specific climate strategies, despite being part of a larger organisation with established commitments.
Roche Holding AG, the parent company, may have its own emissions data and climate targets, which could indirectly impact Roche Diabetes Care's future commitments. As the company continues to align with its parent organisation's sustainability goals, it is expected to develop its own strategies to address carbon emissions and contribute to broader climate action efforts.
No climate goals have been disclosed for Roche Diabetes Care, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Roche Diabetes Care, Inc. yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more